Vijoice
alpelisib
Date of withdrawal:
Last updated:
MedicineHumanWithdrawn application
Piqray
alpelisib
Breast Neoplasms
Date of authorisation:
Revision: 10
Last updated:
MedicineHumanAuthorised
EMEA-002016-PIP03-19-M02 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Other
PIP number: P/0412/2022
Route(s) of administration: Oral use
Pharmaceutical form(s):
Film-coated tablet
Granules
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Aranesp
darbepoetin alfa
Anemia
Cancer
Kidney Failure, Chronic
Date of authorisation:
Revision: 45
Last updated:
MedicineHumanAuthorised
EMEA-002016-PIP04-20 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Oncology
PIP number: P/0122/2021
Route(s) of administration: All routes of administration
Pharmaceutical form(s):
All pharmaceutical forms
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-002016-PIP02-16 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Oncology
PIP number: P/0079/2017
Route(s) of administration: Oral use
Pharmaceutical form(s):
Film-coated tablet
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-000329-PIP02-09-M05 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Oncology
PIP number: P/0147/2016
Route(s) of administration: Subcutaneous useIntravenous use
Pharmaceutical form(s):
Solution for injection
Decision date:
Last updated:
Compliance check: ✔
PIPHuman
Nespo
darbepoetin alfa
Kidney Failure, Chronic
Anemia
Cancer
Date of authorisation:
Revision: 19
Last updated:
MedicineHumanWithdrawn